Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Warner-Lambert describes NK2 antagonists for obesity

Oct. 18, 1996

Antiobesity proteins described by Lilly

Oct. 18, 1996

Anorexigenic dihydropyridine compounds from Bristol-Myers Squibb

Oct. 18, 1996

Lilly claims compounds for women's health

Oct. 18, 1996

Atosiban efficacy in treating preterm labor

Oct. 11, 1996

Yamanouchi awaits marketing approval for new contraceptive

Oct. 11, 1996

Improved formulation of Testoderm available in U.S.

Oct. 11, 1996

Muse approvable for treatment of impotence

Oct. 11, 1996

Aldose reductase inhibitor in phase III at Fujisawa

Oct. 11, 1996

Antidiabetic agents from Yamanouchi's clinical pipeline

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...